You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RGP

Showing 1 - 25 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and A244 rgp120/HIV-1
  • +2 more
  • Baltimore, Maryland
  • +3 more
Oct 28, 2021

Low Vision Trial in Ghent (Scleral contact lens without a passive artificial iris, Scleral contact lens with a passive

Terminated
  • Low Vision
  • Scleral contact lens without a passive artificial iris
  • +3 more
  • Ghent, Belgium
    University Hospital Ghent (UZGent)
Apr 19, 2022

HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, MN rgp120/HIV-1 and A244 rgp120/HIV-1, ALVAC-HIV MN120TMG

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • +3 more
  • Birmingham, Alabama
  • +17 more
Oct 27, 2021

HIV Trial in United States (rgp120/HIV-1MN, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +6 more
Oct 28, 2021

HIV, Pregnancy, HIV Seronegativity Trial (MF59, rgp120/HIV-1 SF-2)

Withdrawn
  • HIV Infections
  • +2 more
  • MF59
  • rgp120/HIV-1 SF-2
  • (no location specified)
Oct 28, 2021

HIV, HIV Seronegativity Trial in Worldwide (ALVAC(2)120(B,MN)GNP (vCP1452), MN rgp120/HIV-1, ALVAC(2)120(B,MN)GNP (vCP1452) )

Completed
  • HIV Infections
  • HIV Seronegativity
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +3 more
  • Rio de Janeiro, Brazil
  • +3 more
Oct 13, 2021

HIV Trial in Saint Louis, Rochester, Seattle (Aluminum hydroxide, Lipid A, Monophosphoryl, Lipid A, Liposome-encapsulated

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +7 more
  • Saint Louis, Missouri
  • +2 more
Oct 28, 2021

HIV Trial in United States (MN rgp120/HIV-1, TBC-3B Vaccine)

Completed
  • HIV Infections
  • MN rgp120/HIV-1
  • TBC-3B Vaccine
  • Baltimore, Maryland
  • +3 more
Oct 27, 2021

HIV Trial in United States (MF59, rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • MF59
  • rgp120/HIV-1 SF-2
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)

Completed
  • HIV Infections
  • HIV Seronegativity
  • Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
  • +3 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

HIV Trial in Birmingham, Saint Louis, Rochester (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +2 more
Oct 28, 2021

HIV Trial in Rochester, Seattle (gp160 Vaccine (Immuno-AG), rgp120/HIV-1IIIB, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • +4 more
  • Rochester, New York
  • +1 more
Oct 28, 2021

HIV Trial in United States (Aluminum hydroxide, QS-21, rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +2 more
  • Saint Louis, Missouri
  • +3 more
Oct 28, 2021

HIV Trial in United States (ALVAC-HIV MN120TMGNP (vCP300), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMGNP (vCP300)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 28, 2021

HIV Trial in United States (ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV MN120TMG (vCP205)
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV, Pregnancy Trial in United States (rgp120/HIV-1MN)

Completed
  • HIV Infections
  • Pregnancy
  • rgp120/HIV-1MN
  • San Francisco, California
  • +5 more
Oct 28, 2021

HIV Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +1 more
Oct 28, 2021

HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))

Completed
  • HIV Infections
  • HIV Seronegativity
  • gp160 Vaccine (Immuno-AG)
  • Saint Louis, Missouri
  • +1 more
Oct 28, 2021

HIV Trial in United States (Aluminum hydroxide, MF59, rgp120/HIV-1IIIB)

Completed
  • HIV Infections
  • Aluminum hydroxide
  • +5 more
  • Los Angeles, California
  • +9 more
Oct 27, 2021

HIV Trial in Stanford (Ritonavir, gp160 Vaccine (Immuno-AG), Stavudine)

Completed
  • HIV Infections
  • Stanford, California
    Stanford CRS
Oct 27, 2021

HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein

Completed
  • HIV Infections
  • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
  • +2 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

HIV, HIV Seronegativity Trial in United States (HIV p24/MF59 Vaccine, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein

Completed
  • HIV Infections
  • HIV Seronegativity
  • HIV p24/MF59 Vaccine
  • +3 more
  • Birmingham, Alabama
  • +6 more
Oct 27, 2021

HIV Trial in Baltimore (ALVAC-HIV gp160MN (vCP125), ALVAC-RG Rabies Glycoprotein (vCP65), rgp120/HIV-1 SF-2)

Completed
  • HIV Infections
  • ALVAC-HIV gp160MN (vCP125)
  • +2 more
  • Baltimore, Maryland
    JHU AVEG
Oct 27, 2021

HIV Trial in Pittsburgh (rgp120/HIV-1 SF-2, Env 2-3, HIVAC-1e)

Completed
  • HIV Infections
  • rgp120/HIV-1 SF-2
  • +3 more
  • Pittsburgh, Pennsylvania
    JHU AVEG
Oct 27, 2021

HIV Trial in Birmingham, Rochester, Seattle (rgp120/HIV-1MN)

Completed
  • HIV Infections
  • rgp120/HIV-1MN
  • Birmingham, Alabama
  • +2 more
Oct 27, 2021